ALBANY, New York, February 15, 2018 /PRNewswire/ --

TMR forecasts the global in vitro diagnostics market will reach US$89,862.2 mn by the end of 2025, from US$55,000 mn in 2016. Between 2017 and 2025, the market is likely to exhibit a CAGR of 5.6%. The presence of a highly sophisticated healthcare industry catapulted North America to the market's fore. The region held lead in the global in vitro diagnostics market in 2016. Based on technology, the global in vitro diagnostics market was led by the clinical chemistry segment, which held approximately 25.2% of the global market in 2016.

Rising Incidence of Chronic Ailments to Fuel Demand for in Vitro Diagnostics 

The demand for in vitro diagnostics has risen in response to the increasing incidence of infectious diseases and chronic ailments worldwide. For instance, the market is likely to benefit from the rising incidence of human immunodeficiency infections, diabetes, obstructive pulmonary diseases, and cancer. In addition, the rising healthcare expenditure and willingness to spend on advanced treatment will create an environment conducive to the market's growth in the coming years. With the demand for minimally invasive and non-invasive diagnostic procedures rising at an impressive pace, the market players can expect newer venues of sales opening up for them during the forecast period. Also, TMR expected the market to benefit from the recent improvements in treatment monitoring and the increased availability for over-the-counter tests.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1395

Unfavorable Reimbursement Policies Could Hamper Growth 

On the downside, complicated and often limited availability of reimbursement policies could restrain the market's trajectory to an extent. However, in the coming years, the in vitro diagnostics market is likely pick pace on account of the rise in epigenomics-based diagnostics tool. Also, it is slated to benefit from the proficiency of molecular diagnostics in identifying diseases at an early stage. With the demand for early and precise diagnosis escalating, the global in vitro diagnostics market is expected to have lucrative prospects to capitalize on in the coming years.

Over the past few decades, the use of in vitro diagnostics was limited to clinical labs alone. For instance, pregnancy tests were always conducted in laboratories. The scenario has hugely changed in the last few years. With recent medical advancements, favorable policies it is now possible to test for pregnancy at home. Besides providing accurate results, these tests are also less time-consuming and can be performed easily. Similar, due to the recent technological advancements, it is possible to measure blood glucose levels and blood pressure home using portable medical devices. These and various other advancements contribute significantly to the growth witnessed in the global in vitro diagnostics market.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1395

To keep pace with competition, companies operating in the global in vitro diagnostics market focus on product development. Besides enabling the market players achieve their growth targets, strategies they adopt also exerts a significant influence on the overall market proceedings. In addition, the companies are likely to engage in research and development activities to offer more precise and accurate methods of diagnosis, finds Transparency Market Research (TMR) in one of its recent reports. Some of the prominent names operating in the global in vitro diagnostics market are Biomerieux SA, Abbott, Danaher Corporation, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Ortho Clinical Diagnostics, Sysmex Corporation, Diasorin and Thermo Fisher Scientific Corporation, Gen-Probe Incorporated, and Life Technologies Corporation, Qiagen N.V. Among these companies, Hoffmann-La Roche Ltd and Abbott currently have a stronger footprint in the overall market.

Purchase your own copy of Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=1395&ltype=S      

This review is based on a TMR, report titled "In Vitro Diagnostics Market (Technology - Point of Care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, and Coagulation and Hemostasis; Application - Drug Testing, Infectious Disease, Oncology, Metabolic Disease, and Autoimmune Disease; End User - Diagnostics Laboratories, Hospitals, Academic & Research Centers, and Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2017-2025."

The global in vitro diagnostics market is segmented as:

Global In Vitro Diagnostics Market, by Technology 

• Point of Care
• Molecular Diagnostics
  • Polymerase Chain Reaction(PCR)
  • Isothermal Nucleic Acid Amplification Technology
  • Microarray
  • Hybridization
  • DNA Sequencing and Next Generation Sequencing
  • Other MDX Technologies
• Immunoassay
  • Enzyme-Linked Immunosorbent Assays (ELISA)
  • Radioimmunoassay (RIA)
  • Enzyme-Linked Immunospot (ELIspot) Assay
  • Rapid Tests
  • Other Immunoassay Techniques
• Clinical Chemistry
  • Basic Metabolic Profile
  • Electrolyte Panel
  • Liver Panel
  • Lipid Panel
  • Renal Panel
  • Thyroid Function Panel
  • Specialty Chemical Tests
• Whole Blood Glucose Monitoring
• Hematology
• Clinical Microbiology
• Coagulation and Hemostasis
• Others

Global In Vitro Diagnostics Market, by Application 

• Drug Testing
• Infectious Disease
• Oncology
• Metabolic Disease
• Autoimmune Disease
• Others

Global In Vitro Diagnostics Market, by End User 

• Diagnostics Laboratories
• Hospitals
• Academic & Research Centers
• Home Care
• Others

Global In Vitro Diagnostics Market, by Geography 

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of the Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

Popular Research Reports by TMR: 

• In Vitro Diagnostics Quality Control Market:   
  

https://www.transparencymarketresearch.com/in-vitro-diagnostics-quality-control-market.html

• Point-of-care Diagnostics Market:   
  

https://www.transparencymarketresearch.com/care-diagnostics-market.html

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Research Blog: https://theglobalhealthnews.com/

SOURCE Transparency Market Research